Amichai, B., Shemer, A. & Grunwald, M.H. (2006). Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol
54(4), 644–646.
Ates, O., Gürsoy, A., Altintas, H., Otük, G. & Birteksöz, S. (2003). Synthesis and antimicrobial activity of [2-[2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino] thiazol-4-yl] acetic acid ethyl esters. Arch Pharm (Weinheim)
336(1), 39–46.
Bojar, R., Holland, K. & Cunliffe, W. (1991). The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strains P37. J Antimicrob Chemother
28(6), 843–853.
Brüggemann, H., Lomholt, H.B. & Kilian, M. (2012). The flexible gene pool of Propionibacterium acnes
. Mob Genet Elements
2(3), 145–148.
Buzea, C., Pacheco, I.I. & Robbie, K. (2007). Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases
2(4), 17–71.
Casimiro, M.H., Leal, J.P., Gil, M.H. & Castro, C.A.N. (2005). Análise calorimétrica aplicada a polímeros biológicos. Parte I: Fundamentos teóricos. Bol–Soc Port Quím
98, 29–36.
Charnock, C., Brudeli, B. & Klaveness, J. (2004). Evaluation of the antibacterial efficacy of diesters of azelaic acid. Eur J Pharm Sci
21(5), 589–596.
Chronnell, C.M., Ghali, L.R., Ali, R.S., Quinn, A.G., Holland, D.B., Bull, J.J., Cunliffe, W.J., McKay, I.A., Philpott, M.P. & Müller-Röver, S. (2001). Human beta defensin-1 and -2 expression in human pilosebaceous units: Upregulation in acne vulgaris lesions. J Invest Dermatol
117(5), 1120–1125.
(2011).
Ganceviciene, R., Bohm, M., Fimmel, S. & Zouboulis, C.C. (2009). The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris. Dermato Endocrinol
1(3), 170–176.
Gollnick, H. (2003). Current concepts of the pathogenesis of acne: Implications for drug treatment. Drugs
63(15), 1579–1596.
Gollnick, H. & Schramm, M. (1998). Topical drug treatment in acne. Dermatology
196(1), 119–125.
Gollnick, H.P., Graupe, K. & Zaumseil, R.P. (2004). Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges
2(10), 841–847.
Ibrahierm, A. & Mansour, M. (2002). Simultaneous determination of azelaic and benzoic acids in topical preparations by liquid chromatography. Chromatographia
7(55), 435–437.
(2005).
Jih, M.H. & Kimyai-Asadi, A. (2007). Laser treatment of acne vulgaris. Semin Plast Surg
21(3), 167–174.
Kilian, M., Scholz, C.F. & Lomholt, H.B. (2012). Multilocus sequence typing and phylogenetic analysis of Propionibacterium acnes
. J Clin Microbiol
50(4), 1158–1165.
Kinney, M.A., Yentzer, B.A., Fleischer, A.B. Jr. & Feldman, S.R. (2010). Trends in the treatment of acne vulgaris: Are measures being taken to avoid antimicrobial resistance?
J Drugs Dermatol
9(5), 519–524.
Knor, T., Meholjić-Fetahović, A. & Mehmedagić, A. (2011). Stratum corneum hydration and skin surface pH in patients with atopic dermatitis. Acta Dermatovenerol Croat
19(4), 242–247.
Liu, C.H. & Huang, H.Y. (2012). Antimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidis
. Chem Pharm Bull
60(9), 1118–1124.
Mainardes, R., Palmira, M., Gremião, D. & Evangelista, R. (2006). Thermoanalytical study of praziquantel-loaded PLGA nanoparticles. Braz J Pharm Sci
42(4), 523–530.
Makadia, H.K. & Siegel, S.J. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers
3(3), 1377–1397.
Makino, K., Mogi, T., Ohtake, N., Yoshida, M., Ando, S., Nakajima, T. & Ohshima, H. (2000). Pulsatile drug release from poly (lactide-co-glycolide) microspheres: How does the composition of the polymer matrices affect the time interval between the initial burst and the pulsatile release of drugs?
Colloids Surf B: Biointerfaces
19(2), 173–179.
Mendham, J., Denney, R., Barnes, J. & Thomas, M. (2000). Thermal analysis. In Vogel's Textbook of Quantitative Chemical Analysis, 6th ed., Mendham, J., Denney, R.C., Barnes, J.D. & Thomas, M. (Eds.), pp. 475–494. Harlow, Essex, UK: Pearson Education Limited.
Morykwas, M.J., Thornton, J.W. & Bartlett, R.H. (1987). Zeta potential of synthetic and biological skin substitutes: Effects on initial adherence. Plast Reconstr Surg
79(5), 732–739.
Mukerjee, A. & Vishwanatha, J. (2009). Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res
29(10), 3867–3875.
Nishijima, S., Kurokawa, I., Katoh, N. & Watanabe, K. (2000). The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. J Dermatol
27(5), 318–323.
Ogiso, T., Yamaguchi, T., Iwaki, M., Tanino, T. & Miyake, Y. (2001). Effect of positively and negatively charged liposomes on skin permeation of drugs. J Drug Target
9(1), 49–59.
Pool, H., Quitanar, D., Figueroa, J., Mano, C., Bechara, J., Godínez, L. & Mendoza, S. (2012). Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles. J Nanomaterials
2012, 1–12.
Purdy, S., Langston, J. & Tait, L. (2003). Presentation and management of acne in primary care: A retrospective cohort study. Br J Gen Pract
53(492), 525–529.
Reis, C., Martinho, N., Rosado, C., Fernandes, A. & Roberto, A. (). Design of polymeric nanoparticles and its potential applications as drug delivery systems for acne treatment. Drug Dev Ind Pharm ().
Sanna, V., Roggio, A.M., Posadino, A.M., Cossu, A., Marceddu, S., Mariani, A., Alzari, V., Uzzau, S., Pintus, G. & Sechi, M. (2011). Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: Formulation, characterization, and cytotoxicity studies. Nanoscale Res Lett
6(1), 260–269.
Schneider, M., Stracke, F., Hansen, S. & Schaefer, U.F. (2009). Nanoparticles and their interactions with the dermal barrier. Dermato Endocrinol
1(4), 197–206.
Seidenari, S., Giusti, F. & Giovanni, P. (2000). Instrumental evaluation of occluded patch test reactions. In Handbook of Non-Invasive Methods and the Skin, Serup, J., Jemec, G.B.E. & Grave, G.L. (Eds.), pp. 973–977. New York: Taylor & Francis.
Shaw, J.C. (2002). Acne: Effect of hormones on pathogenesis and management. Am J Clin Dermatol
3(8), 571–578.
Siepmann, F., Le Brun, V. & Siepmann, J. (2006). Drugs acting as plasticizers in polymeric systems: A quantitative treatment. J Control Release
115(3), 298–306.
Stevanovic, M., Pavlovic, V., Petkovic, J., Filipic, M. & Uskokovic, D. (2011). ROS-inducing potential, influence of different porogens and in vitro degradation of poly (D,L-lactide-co-glycolide)-based material. Express Polym Lett
5(11), 996–1008.
Stinco, G., Bragadin, G., Trotter, D., Pillon, B. & Patrone, P. (2007). Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. J Eur Acad Dermatol Venereol
21(3), 320–325.
Thiboutot, D. (2008). Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol
7(1), 13–16.
Thiboutot, D.M., Fleischer, A.B. Jr., Del Rosso, J.Q. & Graupe, K. (2008). Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol
7(6), 541–546.
Turner, N.G., Cullander, C. & Guy, R.H. (1998). Determination of the pH gradient across the stratum corneum. J Investig Dermatol Symp Proc
3(2), 110–113.
USP (2007).
Vasita, R., Mani, G., Agrawal, C. & Katti, D. (2010). Surface hydrophilization of electrospun PLGA micro-/nanofibers by blending with Pluronic® F-108. Polymer
51(16), 3706–3714.
Wolf, J.E. Jr., Kerrouche, N. & Arsonnaud, S. (2006). Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis
77(4), 3–11.
Wu, Z.M., Ling, L., Zhou, L.Y., Guo, X.D., Jiang, W., Qian, Y., Luo, K.Q. & Zhang, L.J. (2012). Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery. Nanoscale Res Lett
7(1), 299–307.
